How large is the incremental cost relative
to the net beneÔ¨Åt?

One study from the United Kingdom showed
that endovenous therapies were most cost
effective, followed by UGFS, HL&S, and
conservative therapy

Unknown

What would be the effect on health
inequities?

For patients without access, or for whom the
cost of endovenous therapy is prohibitive,
HL&S is an acceptable strategy

Unknown

Is the option acceptable to key
st